InnoVentures Capital Partners is the famous VC, which was founded in 1996.
The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, LODH Immunology Fund, JapanWorks. In the next rounds fund is usually obtained by VI Partners AG, SV Health Investors, Novartis Venture Fund.
The higher amount of exits for fund were in 2009. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2002.
We can highlight the next thriving fund investment areas, such as Internet, Health Care. Among the various public portfolio startups of the fund, we may underline ESBATech Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
Funds with similar focus
Fund Name | Location |
a16z crypto | California, Menlo Park, United States |
Andena Holding | - |
Aser Media | England, London, United Kingdom |
Atlas Ventures | Central, Central Region, Singapore |
Bunge Ventures | - |
Cassia Investments | China, Hong Kong, Hong Kong Island |
Eastven Ericsson Venture Partners | Connecticut, Darien, United States |
Genesys Partners | New York, New York, United States |
Gorilla Capital | Eugene, Oregon, United States |
Ideenschaft Invest GmbH & Co KG | - |
Macquarie Capital | England, London, United Kingdom |
Mars Growth Capital | Central, Central Region, Singapore |
Northwest Georgia Bank | Georgia, Ringgold, United States |
Polsky Holdings | Chicago, Illinois, United States |
RBC Dain Rauscher | Minneapolis, Minnesota, United States |
Seedline | Greencastle, Indiana, United States |
Startup Holding | Latvia, Riga, Vidzeme |
Variant | - |
Washington State Housing Finance Commission | Seattle, United States, Washington |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ESBATech | $15M | 14 May 2002 | Zurich, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ESBATech | $15M | 14 May 2002 | Zurich, Switzerland |